Who Owns Kyntra Bio Stock?
NASDAQ: KYNBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 24.68%
- Held by insiders
- 2.02%
- Institutional holders
- 36
- Institutions 24.7%
- Insiders 2.0%
- Public and other 73.3%
Who owns Kyntra Bio stock?
Institutional investors own about 24.7% of Kyntra Bio's shares, spread across 36 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.02% of KYNB.
The largest institutional holders are Armistice Capital, LLC (9.88%), Vanguard Capital Management LLC (3.95%) and Acadian Asset Management. LLC (2.61%). Together, the top 10 institutions control 23.4% of shares outstanding. In their latest filings, 3 of the top 10 institutions increased their KYNB positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KYNB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 400.00K | 9.88% | 0.0% |
| Vanguard Capital Management LLC | 159.95K | 3.95% | +2.1% |
| Acadian Asset Management. LLC | 105.58K | 2.61% | 0.0% |
| Blackrock Inc. | 84.33K | 2.08% | 0.0% |
| Geode Capital Management, LLC | 43.22K | 1.07% | -6.0% |
| HighTower Advisors, LLC | 39.75K | 0.98% | +0.0% |
| Two Sigma Investments, LP | 39.51K | 0.98% | -20.2% |
| Renaissance Technologies, LLC | 27.08K | 0.67% | -1.5% |
| Vanguard Fiduciary Trust Co | 24.11K | 0.60% | +0.7% |
| Birchview Capital, LP | 22.57K | 0.56% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KYNB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 114.18K | 2.82% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 42.27K | 1.04% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 19.02K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 7.00K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 5.74K | 0.14% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 3.51K | 0.09% |
| VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund | 2.72K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 1.99K | 0.05% |
| Blackstone Alternative Investment Fd.s-Blackstone Alternative Multi-St | 185 | 0.00% |
| ADVISORS' INNER CIRCLE III-Knights of Columbus U.S. All Cap Index Fund | 22 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Kyntra Bio?
Armistice Capital, LLC is the largest institutional shareholder of KYNB, owning 9.88% of shares outstanding (400.00K shares) as of its latest 13F filing.
What percentage of Kyntra Bio is owned by institutions?
Institutions own about 24.7% of KYNB shares and 25.2% of the public float.
How much of Kyntra Bio do insiders own?
Insiders, such as officers and directors, own about 2.02% of KYNB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.